Traws Pharma, Inc. (TRAW)
0.416
-0.03
(-6.56%)
USD |
NASDAQ |
Oct 12, 16:00
0.42
0.00 (0.00%)
Pre-Market: 08:19
Traws Pharma Net Income (Quarterly) : -3.054M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.054M |
| March 31, 2026 | -7.107M |
| December 31, 2025 | -7.443M |
| September 30, 2025 | -3.962M |
| June 30, 2025 | -0.915M |
| March 31, 2025 | 21.49M |
| December 31, 2024 | -29.92M |
| September 30, 2024 | -8.475M |
| June 30, 2024 | -123.14M |
| March 31, 2024 | -4.983M |
| December 31, 2023 | -4.184M |
| September 30, 2023 | -4.739M |
| June 30, 2023 | -4.25M |
| March 31, 2023 | -5.775M |
| December 31, 2022 | -5.42M |
| September 30, 2022 | -5.398M |
| June 30, 2022 | -4.024M |
| March 31, 2022 | -4.122M |
| December 31, 2021 | -3.764M |
| September 30, 2021 | -3.453M |
| June 30, 2021 | -4.231M |
| March 31, 2021 | -4.715M |
| December 31, 2020 | -6.429M |
| September 30, 2020 | -6.241M |
| June 30, 2020 | -7.395M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.092M |
| December 31, 2019 | -5.747M |
| September 30, 2019 | -4.595M |
| June 30, 2019 | -3.561M |
| March 31, 2019 | -7.60M |
| December 31, 2018 | -5.651M |
| September 30, 2018 | -5.348M |
| June 30, 2018 | -4.321M |
| March 31, 2018 | -5.09M |
| December 31, 2017 | -6.207M |
| September 30, 2017 | -6.961M |
| June 30, 2017 | -2.584M |
| March 31, 2017 | -8.341M |
| December 31, 2016 | -5.447M |
| September 30, 2016 | -1.599M |
| June 30, 2016 | -5.381M |
| March 31, 2016 | -7.24M |
| December 31, 2015 | 3.192M |
| September 30, 2015 | -5.873M |
| June 30, 2015 | -8.975M |
| March 31, 2015 | -12.37M |
| December 31, 2014 | -13.39M |
| September 30, 2014 | -14.91M |
| June 30, 2014 | -16.78M |
| March 31, 2014 | -18.72M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.054M |
| EPS Diluted (Quarterly) | -0.1924 |
| Enterprise Value | 1.337M |
| Earnings Yield | -555.1% |
| Normalized Earnings Yield | -552.84 |